| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.19 |
5e-05 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.001 |
| mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.008 |
| mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |